RESEARCH FUNDS IN THE HEALTH SECTOR

DEADLINE: NOVEMBER 10^th, 2010

MAIN AREAS OF INTERVENTION:

1.     BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH

a.       High throughput proteomics for human health and disease

b.       High impact research initiative for better immunization

c.       New therapeutic approaches in chronic inflammatory and autoimmune diseases.

  

2.     TRANSLATING RESEARCH FOR HUMAN HEALTH

·         INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA GATHERING, SYSTEMS BIOLOGY:

a.       High impact research initiative on the human epigenome

b.       Population genetics studies on cardio-metabolic disorders in EU/AC and EECA populations

·         RESEARCH ON THE BRAIN AND RELATED DISEASES, HUMAN DEVELOPMENT AND AGEING

a.       Creating clinical and molecular tools for experimental therapy of paediatric neurodegenerative disorders causing childhood dementia in Europe and India

b.       Management of Gram negative multi-drug resistant infections

·         TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH

a.       ANTIMICROBIAL DRUG RESISTANCE: Multidisciplinary research on the evolution and transfer of antibiotic resistance

b.       EMERGING EPIDEMICS: Comprehensive control of Dengue fever under changing climatic conditions

·         TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES:

a.       Epidemiology and aetiology of infection-related cancers

 3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN CITIZENS

·       HEALTH PROMOTION

a.       Developing and implementing methods for the transfer of research into policy in the fields of health promotion and disease prevention

b.       A road-map for mental health research in Europe

·       INTERNATIONAL PUBLIC HEALTH & HEALTH SYSTEMS

a.       Development and assessment of comprehensive and integrated interventions and programmes to improve reproductive health and health equity

b.       Building sustainable capacity for research for health and its social determinants in low and middle income countries

c.        Multilateral cooperation between Europe, Africa and Latin America on public health and health services research

4. OTHER ACTIONS ACROSS THE HEALTH THEME

a.       Networking of major research institutions to coordinate communication actions aimed at the media and the general public

b.       Targeting publication bias

c.        Linking EU and Latin American policy making institutions in the field of health research

d.       Organisation of supporting actions and events related to the Presidency of the European Union

·         RESPONDING TO EU POLICY NEEDS

a.       Investigator driven clinical trials on off-patent  medicines for children

b.       Adverse drug reaction research

c.       New methodologies for clinical trials in personalised medicine

For further information, please contact infonetwork@igcsas.it